ASNC-Comments-to-CMS-on-Medicare-Advantage-Proposed-Rule_01-27-2025
ASNC asked the Centers for Medicare & Medicaid Services to finalize several proposals that would make it harder for Medicare Advantage (MA) plans to use certain internal coverage criteria or policies and guidelines when making coverage decisions. In this letter, ASNC also discussed the policies of some insurance companies that automatically deny coverage of cardiac PET and other appropriate functional stress tests for the evaluation of stable chest pain and require CCTA as a first-line test. ASNC also voiced support for greater disclosure of prior authorization use by MA organizations, including requiring that the percentage of prior authorization denials and approvals must be reported at the item and service level, rather than in aggregate.
Related Resources
PET Case: Identifying Epicardial Coronary Artery Disease in a Patient With Paroxysmal Atrial Fibrillation Using [15O]H2O PET
Case summary: This case highlights the ability of [15O]H2O PET to accurately…
ASNC, ACC Comment to Commerce Department on Radiopharmaceutical Imports
ASNC-ACC-Radiopharms-Tariff-Letter_05-07-2025 ASNC and the American College of Cardiology submitted comments on a…
PET Case: Very High-Risk PET MPI
Case summary: This case illustrates the value of cardiac PET MPI for…